![](https://unicorn-nest.com/wp-content/uploads/2021/11/Jianxin-Capital.png?x55332)
Related Funds
Funds with similar focus
Fund Name | Location |
Allegis Capital | California, San Francisco, United States |
Biomatics Capital Partners | Seattle, United States, Washington |
Cathay Capital | Beijing, Beijing, China |
Changxiang Entertainment | Beijing, China, Shijingshan |
Citizens National Bank | Fort Worth, Texas, United States |
FacePaint | New York, New York, United States |
Florida Growth Fund | Florida, Fort Lauderdale, United States |
G2H2 Capital | New York, New York, United States |
Guava Capital | - |
Haier Open Partnership Ecosystem (HOPE) | China, Japan, Kagoshima Prefecture |
Hokkaido Venture Capital | Hokkaido Prefecture, Japan, Sapporo |
Lafayette Group | United States, Vienna, Virginia |
Nazca Ventures | - |
Norvestor Equity | Norway, Oslo |
Sagene Tech Ventures | Norway, Oslo |
Shenzhen Wangyu | China, Guangdong, Shenzhen |
Stahl Invest | - |
Stonewood Capital Management | Pennsylvania, Pittsburgh, United States |
Winfield Capital Corp | New York, United States, White Plains |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Hegea Bio | $15M | 28 Mar 2024 | Shanghai, Shanghai, China | ||
Isabers | $34M | 18 May 2023 | Beijing, Beijing, China | ||
Meike Solar | $185M | 21 Dec 2021 | Yangzhong, Jiangsu, China | ||
Abbisko Therapeutics | $70M | 25 Mar 2020 | China, Shanghai | ||
Leads Biolabs | 29 Aug 2018 | Nanjing, Jiangsu, China | |||
Sumgen Biotech | $7M | 27 Jul 2018 | China, Zhejiang | ||
Eastern Biotech | $463K | 06 Feb 2018 | Dongcheng District, Beijing, China | ||
Huadao Biopharma | $463K | 08 Nov 2017 | Shanghai, China | ||
Leads Biolabs | 03 Jul 2017 | Nanjing, Jiangsu, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Hegea Bio | $15M | 28 Mar 2024 | Shanghai, Shanghai, China | ||
Isabers | $34M | 18 May 2023 | Beijing, Beijing, China | ||
Meike Solar | $185M | 21 Dec 2021 | Yangzhong, Jiangsu, China | ||
Abbisko Therapeutics | $70M | 25 Mar 2020 | China, Shanghai | ||
Leads Biolabs | 29 Aug 2018 | Nanjing, Jiangsu, China | |||
Sumgen Biotech | $7M | 27 Jul 2018 | China, Zhejiang | ||
Eastern Biotech | $463K | 06 Feb 2018 | Dongcheng District, Beijing, China | ||
Huadao Biopharma | $463K | 08 Nov 2017 | Shanghai, China | ||
Leads Biolabs | 03 Jul 2017 | Nanjing, Jiangsu, China |